Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention. | Cancers (Basel) | 2022 | 35740692 | PubTator, text mining | PubMed |
| Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC. | Cancers (Basel) | 2022 | 35740564 | PubTator, text mining | PubMed |
| Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome. | Cancers (Basel) | 2022 | 35740513 | PubTator, text mining | PubMed |
| Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy. | Cancer Manag Res | 2022 | 35720644 | PubTator, text mining | PubMed |
| From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement. | Front Immunol | 2022 | 35720368 | PubTator, text mining | PubMed |
| Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia. | Proc Natl Acad Sci U S A | 2022 | 35696582 | PubTator, text mining | PubMed |
Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. | Front Immunol | 2022 | 35693827 | PubTator, text mining | PubMed |
| Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. | PLoS One | 2022 | 35679246 | PubTator, text mining | PubMed |
| Modified dendritic cell-derived exosomes activate both NK cells and T cells through the NKG2D/NKG2D-L pathway to kill CML cells with or without T315I mutation. | Exp Hematol Oncol | 2022 | 35672796 | PubTator, text mining | PubMed |
| The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. | Front Immunol | 2022 | 35669776 | PubTator, text mining | PubMed |
| Omics Biomarkers for Monitoring Tuberculosis Treatment: A Mini-Review of Recent Insights and Future Approaches. | Infect Drug Resist | 2022 | 35664683 | PubTator, text mining | PubMed |
| Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. | Cancer Cell | 2022 | 35660135 | PubTator, text mining | PubMed |
| Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease. | Biomed Pharmacother | 2022 | 35658218 | PubTator, text mining | PubMed |
| TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy. | Oncoimmunology | 2022 | 35646475 | PubTator, text mining | PubMed |
| Update on the pathogenesis of vitiligo. | An Bras Dermatol | 2022 | 35643735 | PubTator, text mining | PubMed |
| Immunopathogenic overlap between COVID-19 and tuberculosis identified from transcriptomic meta-analysis and human macrophage infection. | iScience | 2022 | 35634577 | PubTator, text mining | PubMed |
| The effect of the probiotic consortia on SARS-CoV-2 infection in ferrets and on human immune cell response in vitro. | iScience | 2022 | 35634575 | PubTator, text mining | PubMed |
Intense Innate Immune Responses and Severe Metabolic Disorders in Chicken Embryonic Visceral Tissues Caused by Infection with Highly Virulent Newcastle Disease Virus Compared to the Avirulent Virus: A Bioinformatics Analysis. | Viruses | 2022 | 35632651 | PubTator, text mining | PubMed |
| Influence of Nutritional Status and Physical Exercise on Immune Response in Metabolic Syndrome. | Nutrients | 2022 | 35631195 | PubTator, text mining | PubMed |
| Exploring the Utility of NK Cells in COVID-19. | Biomedicines | 2022 | 35625739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=28